Not so long ago Habré mentioned project Calico, a subsidiary of Google, founded to explore the issues of longevity and the fight against all sorts of age-related diseases. It seems that the project gets new blood in the form of a large number of funds, namely - one and a half billion dollars.
All the money will be invested not only the corporation Google, but now a new partner: pharmaceutical giant Chicago AbbVie.
Each of the partners in the project initially will invest $ 250 million, with a further opportunity to report on more than $ 500 million. All the money will be used to create a new research center in San Francisco. The center, as planned, will operate a large team of scientists whose aim - to get new medicines for age-related diseases.
In AbbVie main task is to clinical trials of new drugs, with further access of these drugs on the market. According to the management of the project Calico, a partnership with AbbVie opens up tremendous opportunities for the future work of the project.
It is worth mentioning that the project was announced Calico Google guides as a means of "treatment of death." Now cleared the project objectives and the methods to be used to achieve the main goal, also became clearer: it is the creation of new drugs for treatment or prevention of Alzheimer's disease, Parkinson's, cancer and other diseases.
Via
theverge
Source:
habrahabr.ru/post/235635/